Home › Funds › EASTERLY INVESTMENT PARTNERS LLC › PCRX
EASTERLY INVESTMENT PARTNERS LLC position in PCRX
PACIRA BIOSCIENCES INC COM · Health Care
EASTERLY INVESTMENT PARTNERS LLC reported holding 337,019 shares of PCRX (PACIRA BIOSCIENCES INC COM) in its Q2 2026 13F filing — a position valued at US$8.6M, representing 0.44% of its reported portfolio and ranking #47 among its reported holdings. EASTERLY INVESTMENT PARTNERS LLC has disclosed PCRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EASTERLY INVESTMENT PARTNERS LLC's PCRX position evolved
EASTERLY INVESTMENT PARTNERS LLC first disclosed a stake in PCRX in Q3 2023 at 37,850 shares (US$1.2M). The position peaked in Q2 2026 at 337,019 shares, worth US$8.6M. Across 12 filings, EASTERLY INVESTMENT PARTNERS LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 337,019 shares valued at US$8.6M — an increase of 2,165 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2023 (shares fell 13% over the following quarter), a 52% increase in Q2 2025 (shares rose 8% over the following quarter), a 46% increase in Q3 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 37.85K | $1.16M | New |
| Q4 2023 | 55.44K | $1.87M | Add |
| Q1 2024 | 79.32K | $2.32M | Add |
| Q2 2024 | 105.56K | $3.02M | Add |
| Q3 2024 | 134.48K | $2.02M | Add |
| Q4 2024 | 105.65K | $1.99M | Reduce |
| Q1 2025 | 112.17K | $2.79M | Add |
| Q2 2025 | 170.07K | $4.06M | Add |
| Q3 2025 | 249.11K | $6.42M | Add |
| Q4 2025 | 251.85K | $6.52M | Add |
| Q1 2026 | 334.85K | $7.66M | Add |
| Q2 2026 | 337.02K | $8.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PCRX and 13F data
PCRX (PACIRA BIOSCIENCES INC COM) is a Health Care company. 24 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$88.7M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PCRX
- Context Capital Management, LLC 88.81M sh · $88.73M · Q2 2026
- Doma Perpetual Capital Management LLC 2.78M sh · $70.47M · Q2 2026
- GAGNON SECURITIES LLC 608.62K sh · $15.44M · Q2 2026
More on EASTERLY INVESTMENT PARTNERS LLC
FAQ
How long has EASTERLY INVESTMENT PARTNERS LLC held PCRX?
EASTERLY INVESTMENT PARTNERS LLC has disclosed PCRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is EASTERLY INVESTMENT PARTNERS LLC's current position in PCRX?
As of Q2 2026, EASTERLY INVESTMENT PARTNERS LLC holds 337.02K shares of PCRX (PACIRA BIOSCIENCES INC COM), valued at $8.55M, representing 0.44% of its reported portfolio and ranking #47.
Has EASTERLY INVESTMENT PARTNERS LLC been buying or selling PCRX?
In the latest 13F filing (Q2 2026), EASTERLY INVESTMENT PARTNERS LLC increased its position in PCRX. The position peaked in Q2 2026 at 337.02K shares.
Which other funds hold PCRX?
Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.